help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, S.
Right arrow Articles by Stallcup, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, S.
Right arrow Articles by Stallcup, M. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DEXAMETHASONE
Medline Plus Health Information
*Steroids

Molecular Endocrinology, Vol 9, 826-837, Copyright © 1995 by Endocrine Society


ARTICLES

A somatic cell genetic method for identification of untargeted mutations in the glucocorticoid receptor that cause hormone binding deficiencies

S Lee, KA Duncan, H Chou, D Chen, K Kohli, CF Huang and MR Stallcup
Department of Pathology, University of Southern California Health Sciences Campus, Los Angeles 90033, USA.

Mouse T lymphoma cell line W7MG1, which is killed by physiological concentrations of glucocorticoid agonists, was used as a convenient genetic system for isolating sublines containing mutant glucocorticoid receptors (GR) with hormone-binding deficiencies. Partially hormone- resistant cell clones were derived from chemically mutagenized cell populations by selecting for growth in moderate concentrations of dexamethasone (Dex) and then screening for failure to grow in high Dex concentrations. Such clones are likely to have mutant GR. In GR cDNA clones from the partially resistant cell sublines, three different functionally significant mutations in the hormone-binding domain were identified: Leu-569 changed to Phe (L569F), Leu-670 to Phe (L670F), and Met-672 to Ile (M672I). Dose-response analyses with Dex and affinity labeling studies with dexamethasone 21-mesylate in transiently transfected cells indicated that all three mutant GR species had hormone-binding deficiencies. However, at saturating Dex concentrations the mutant and wild type GR activated a hormone-inducible reporter gene to the same extent; thus, these three mutations did not affect the ability of GR to activate transcription of the reporter gene after hormone was bound. In dose-response curves conducted with several glucocorticoid agonists, mutations L670F and M672I caused no change in ligand-binding specificities, while mutation L569F caused a modest change in specificity. Quantitative hormone-binding studies conducted with mutant GR synthesized in cell-free reactions showed that mutant GR species L569F and M672I had reduced Dex-binding affinities both at 0 C and at 22 C in the presence of molybdate. In contrast, for the L670F mutant, which exhibited the severest deficiency in vivo, the hormone- binding deficiency in the cell-free system was evident only at 26-37 C and primarily in the absence of molybdate. We propose that the L670F GR is an activation-labile type of mutant, which binds hormone normally in the presence of heat shock protein 90 but loses hormone rapidly after dissociation from heat shock protein 90. These three mutations define two new subregions of the GR polypeptide that are important for hormone binding.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Fang, D. Ricketson, L. Getubig, and B. Darimont
Unliganded and hormone-bound glucocorticoid receptors interact with distinct hydrophobic sites in the Hsp90 C-terminal domain
PNAS, December 5, 2006; 103(49): 18487 - 18492.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Ruegg, F. Holsboer, C. Turck, and T. Rein
Cofilin 1 Is Revealed as an Inhibitor of Glucocorticoid Receptor by Analysis of Hormone-Resistant Cells
Mol. Cell. Biol., November 1, 2004; 24(21): 9371 - 9382.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. G. Hillmann, J. Ramdas, K. Multanen, M. R. Norman, and J. M. Harmon
Glucocorticoid Receptor Gene Mutations in Leukemic Cells Acquired in Vitro and in Vivo
Cancer Res., April 1, 2000; 60(7): 2056 - 2062.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
G. Giannoukos, A. M. Silverstein, W. B. Pratt, and S. S. Simons Jr.
The Seven Amino Acids (547-553) of Rat Glucocorticoid Receptor Required for Steroid and Hsp90 Binding Contain a Functionally Independent LXXLL Motif That Is Critical for Steroid Binding
J. Biol. Chem., December 17, 1999; 274(51): 36527 - 36536.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Roux, B. Terouanne, B. Couette, M.-E. Rafestin-Oblin, and J.-C. Nicolas
Conformational Change in the Human Glucocorticoid Receptor Induced by Ligand Binding Is Altered by Mutation of Isoleucine 747 by a Threonine
J. Biol. Chem., April 9, 1999; 274(15): 10059 - 10065.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. Milhon, S. Lee, K. Kohli, D. Chen, H. Hong, and M. R. Stallcup
Identification of Amino Acids in the {tau}2-Region of the Mouse Glucocorticoid Receptor That Contribute to Hormone Binding and Transcriptional Activation
Mol. Endocrinol., November 1, 1997; 11(12): 1795 - 1805.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society